SCHEMBL360284

SCHEMBL360284

O=[N+]([O-])c1ccc(O)c(CCl)c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.56
GPR35 Q9HC97 2/20 0.56
ALDH1A1 P00352 2/20 0.56
TP53 P04637 1/20 0.56
HPGD P15428 1/20 0.56
MAPK1 P28482 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
GAA P10253 1/20 0.55
THRB P10828 1/20 0.55
CTSB P07858 1/20 0.54
ERN1 O75460 1/20 0.51
NOX4 Q9NPH5 1/20 0.49
APP P05067 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
HSD17B10 Q99714 1/20 0.46
HSP90AA1 P07900 1/20 0.45
MEN1 O00255 1/20 0.45
CRHBP P24387 1/20 0.45
KMT2A Q03164 1/20 0.45
CRHR2 Q13324 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL30105737 0.98 TSHR (0.55) TSHRGPR35ALDH1A1TP53HPGD
1,2-Dichloroethane SCHEMBL28304825 0.96 TSHR (0.53) TSHRGPR35ALDH1A1TP53HPGD
SCHEMBL17627174 0.85 GPR35 (0.56) TSHRGPR35ALDH1A1TP53HPGD
SCHEMBL51277 0.85 GPR35 (0.60) TSHRGPR35ALDH1A1TP53HPGD
SCHEMBL4231830 0.83 ALDH1A1 (0.58) TSHRGPR35ALDH1A1TP53HPGD
SCHEMBL216753 0.83 GPR35 (0.58) TSHRGPR35ALDH1A1TP53HPGD
SCHEMBL786832 0.81 GAA (0.59) TSHRGPR35ALDH1A1TP53HPGD
Hydrochloric Acid SCHEMBL22773531 0.81 GPR35 (0.56) TSHRGPR35ALDH1A1TP53HPGD
SCHEMBL131912 0.81 GPR35 (0.56) TSHRGPR35ALDH1A1TP53HPGD
SCHEMBL786831 0.81 ALDH1A1 (0.56) TSHRGPR35ALDH1A1TP53HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115594601-B Method for preparing Saimiqili intermediate 2-methyl-4-aminophenol 山东国邦药业有限公司 2023-02-28 CN claimed
CN-115594601-A Method for preparing Saimiqili intermediate 2-methyl-4-aminophenol 山东国邦药业有限公司(CN) 2023-01-13 CN claimed
CN-115385880-A Industrial preparation method of environment-friendly dronedarone key intermediate 南京方生和医药科技有限公司 2022-11-25 CN claimed
CN-113354657-B Mytoxin A prodrug and preparation method and application thereof 国家纳米科学中心 2022-10-21 CN claimed
CN-113321698-B Monomethyl auristatin E prodrug and preparation method and application thereof 国家纳米科学中心 2022-08-23 CN claimed
CN-113321702-B Monomethyl auristatin F methyl ester prodrug and preparation method and application thereof 国家纳米科学中心 2022-08-05 CN claimed
CN-109651394-B Benzoindolo [2,1-b ] [1,3] oxazine derivative cyanide ion probe and application thereof 山东第一医科大学(山东省医学科学院) 2021-07-20 CN claimed
CN-109970693-A A kind of preparation method of dronedarone key intermediate 南京方生和医药科技有限公司 2019-07-05 CN claimed
CN-105936626-A Preparation method of amino protection group 济南大学 2016-09-14 CN claimed
EP-2718393-B1 NEW PHOTOCHROMIC COMPOUNDS, METHOD OF PRODUCTION THEREOF AND INTERMEDIATE COMPOUNDS KAUNAS UNIVERSITY OF TECHNOLOGY (LT) 2015-08-05 EP claimed
CN-102659726-B Method for synthesis of dronedarone FUJIAN COSUNTER PHARMACEUTICAL CO LTD 2014-11-19 CN claimed
EP-2718393-A1 NEW PHOTOCHROMIC COMPOUNDS, METHOD OF PRODUCTION THEREOF AND INTERMEDIATE COMPOUNDS Kauno Technologijos Universitetas (LT) 2014-04-16 EP claimed
WO-2014035224-A1 NEW PHOTOCHROMIC COMPOUNDS, METHOD OF PRODUCTION THEREOF AND INTERMEDIATE COMPOUNDS Kauno technologijos universitetas (LT) 2014-03-06 WO claimed
CN-102659726-A Method for synthesis of dronedarone FUJIAN GUANGSHENGTANG PHARMACEUTICAL CO LTD 2012-09-12 CN claimed
EP-0180785-A1 Pharmaceutical preparation containing a combination of Nitrendipin and Enalapril and process for its preparation BAYER AG (DE) 1986-05-14 EP claimed
US-20250257069-A1 JAK INHIBITOR ANALOGS, FORMULATIONS, AND USES THEREOF THE REGENTS OF THE UNIVERSITY OF MICHIGAN 2025-08-14 US disclosed
US-12378199-B2 Rigidified pentadentate chelating agents useful for the [Al18F]2+ labelling of biomolecules UNIVERSITÀ DEGLI STUDI DEL PIEMONTE ORIENTALE “A. AVOGADRO” (IT) 2025-08-05 US disclosed
US-4122256-A OPTICAL BRIGHTENERS HOECHST AKTIENGESELLSCHAFT (DE) 1978-10-24 US disclosed
US-4052433-A INTERMEDIATES FOR BENZOFURANS HOECHST AKTIENGESELLSCHAFT (DT) 1977-10-04 US disclosed
US-3994879-A CONDENSING AZOMETHINES, OPTICAL BRIGHTENERS HOECHST AKTIENGESELLSCHAFT (DT) 1976-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250257069-A1 JAK INHIBITOR ANALOGS, FORMULATIONS, AND USES THEREOF JAK1, JAK3, JAK2 TSHR 3612/4885GPR35 1683/4885ALDH1A1 2402/4885
US-12378199-B2 Rigidified pentadentate chelating agents useful for the [Al18F]2+ labelling of biomolecules SLC29A1, APRT, SLC29A2 TSHR 2022/4885GPR35 3482/4885ALDH1A1 1747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.